Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study.
Saved in:
| Title: | Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study. |
|---|---|
| Authors: | Moldovan, D.1 moldovan.dumitru@gmail.com, Reshef, A.2, Fabiani, J.3, Kivity, S.4, Toubi, E.5, Shlesinger, M.6, Triggiani, M.7, Montinaro, V.8, Cillari, E.9, Realdi, G.10, Cancian, M.10, Visscher, S.11, Zanichelli, A.12, Relan, A.11, Cicardi, M.12 |
| Source: | Clinical & Experimental Allergy. Jun2012, Vol. 42 Issue 6, p929-935. 7p. 7 Charts, 3 Graphs. |
| Database: | Environment Complete |
Be the first to leave a comment!
